EUVIMEDEUVIMED entdecken
Metaanalyse

Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapies

Adel Shahnam, Nadia Hitchen, Udit Nindra, Sathya Manoharan, Jayesh Desai, Ben Tran, Benjamin Solomon, Stephen J Luen, Rina Hui, Ashley M Hopkins, Michael J Sorich

European Journal of Cancer · 2024-02 · 198 · 113503

DOI: 10.1016/j.ejca.2023.113503 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift European Journal of Cancer, 2024-02. Verfasst von Adel Shahnam und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Peter McCallum Cancer Centre, Melbourne, VIC, Australia. Electronic address: adel.shahnam@petermac.org. Hauptthemen laut MEDLINE: Melanoma, Pancreatic Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Cancer Council South Australia, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaPancreatic NeoplasmsHumansBiomarkersDisease-Free SurvivalProgression-Free SurvivalRandomized Controlled Trials as TopicClinical Trials, Phase III as Topic

Stichwörter der Autor:innen

Objective responseOverall survivalProgression free survivalSurrogacy

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Medical Oncology, Peter McCallum Cancer Centre, Melbourne, VIC, Australia. Electronic address: adel.shahnam@petermac.org.
  • Department of Medical Oncology, Peter McCallum Cancer Centre, Melbourne, VIC, Australia.
  • Department of Medical Oncology, Liverpool Hospital, Sydney, New South Wales, Australia.
  • Department of Medical Oncology, Peter McCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.
  • The Centre of Cancer Medicine, University Hong Kong, Hong Kong.
  • College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.

Förderung

  • Cancer Council South Australia
  • National Health and Medical Research Council

Zitieren

APA

Shahnam, A., Hitchen, N., Nindra, U., Manoharan, S., Desai, J., Tran, B., Solomon, B., Luen, S. J., Hui, R., Hopkins, A. M., & Sorich, M. J. (2024). Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapies. European Journal of Cancer, 198, 113503. https://doi.org/10.1016/j.ejca.2023.113503

Vancouver

Shahnam A, Hitchen N, Nindra U, Manoharan S, Desai J, Tran B, et al. Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapies. European Journal of Cancer. 2024;198:113503. doi:10.1016/j.ejca.2023.113503

BibTeX
@article{Shahnam2024,
  author = {Shahnam, Adel and Hitchen, Nadia and Nindra, Udit and Manoharan, Sathya and Desai, Jayesh and Tran, Ben and Solomon, Benjamin and Luen, Stephen J and Hui, Rina and Hopkins, Ashley M and Sorich, Michael J},
  title = {Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapies},
  journal = {European Journal of Cancer},
  year = {2024},
  volume = {198},
  pages = {113503},
  doi = {10.1016/j.ejca.2023.113503}
}
Kostenlos starten →